Skip to main content

Advertisement

Log in

Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Purpose

Race/ethnicity have been previously shown to significantly affect survival after diagnosis with glioblastoma, but the cause of this survival difference is not known. The aim of this study was to examine variation in treatment pattern and time to treatment by race/ethnicity, and the extent to which this affects survival.

Methods

Data were obtained from the National Cancer Database (NCDB) for adults ≥ 40 with glioblastoma from 2004 to 2016 (N = 68,979). Treatment patterns and time to treatment by race/ethnicity were compared using univariable and multivariable logistic and linear regression models, respectively, and adjusted for known prognostic factors and factors potentially affecting health care access.

Results

Black non-Hispanics (BNH) and Hispanics were less likely to receive radiation and less likely to receive chemotherapy as compared to White non-Hispanics (WNH). Time to radiation initiation was ~ 2 days longer and time to chemotherapy initiation was ~ 4 days longer in both groups in comparison to WNH.

Conclusion

Both race/ethnicity and treatment timing significantly affected survival time, and this association remained after adjustment for known prognostic factors. Additional research is necessary to disentangle the specific causal factors, and the mechanism with which they affect survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The National Cancer Database (NCDB) data that support the findings of this study are available from American College of Surgeons and the American Cancer Society. Restrictions apply to the availability of these data, which were used under license for this study. Data are available at https://www.facs.org/quality-programs/cancer/ncdb for investigators at Commission on Cancer (CoC) accredited facilities with an approved data request.

References

  1. Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS Statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol 22:iv1–iv96. https://doi.org/10.1093/neuonc/noaa200

    Article  PubMed  Google Scholar 

  2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl J Med 352:987–996. https://doi.org/10.1056/NEJMoa043330

    Article  CAS  PubMed  Google Scholar 

  3. Dressler EV, Liu M, Garcia CR, Dolecek TA, Pittman T, Huang B, Villano JL (2019) Patterns and disparities of care in glioblastoma. Neurooncol Pract 6:37–46. https://doi.org/10.1093/nop/npy014

    Article  PubMed  Google Scholar 

  4. Lu VM, Shah AH, Eichberg DG, Quinones-Hinojosa A, Esquenazi Y, Komotar RJ, Ivan ME (2020) Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: insights from a national database. J Neurooncol 147:711–720. https://doi.org/10.1007/s11060-020-03480-1

    Article  PubMed  Google Scholar 

  5. Patel NP, Lyon KA, Huang JH (2019) The effect of race on the prognosis of the glioblastoma patient: a brief review. Neurol Res 41:967–971. https://doi.org/10.1080/01616412.2019.1638018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mandel JJ, Youssef M, Nam J, Patel AJ, Jalali A, Ludmir EB, Liu D, Wu J, Armstrong G, Huse J, Bondy M, de Groot JF (2019) Effect of health disparities on overall survival of patients with glioblastoma. J Neurooncol 142:365–374. https://doi.org/10.1007/s11060-019-03108-z

    Article  PubMed  Google Scholar 

  7. Seidlitz A, Siepmann T, Löck S, Juratli T, Baumann M, Krause M (2015) Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme. Radiat Oncol 10:172. https://doi.org/10.1186/s13014-015-0478-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS (2018) Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014. JAMA Oncol 4:1254–1262. https://doi.org/10.1001/jamaoncol.2018.1789

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hauser A, Dutta SW, Showalter TN, Sheehan JP, Grover S, Trifiletti DM (2018) Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma. J Clin Neurosci 47:103–110. https://doi.org/10.1016/j.jocn.2017.10.087

    Article  PubMed  Google Scholar 

  10. Rhome R, Fisher R, Hormigo A, Parikh RR (2016) Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma. J Neurooncol 128:241–250. https://doi.org/10.1007/s11060-016-2101-5

    Article  CAS  PubMed  Google Scholar 

  11. Bohn A, Braley A, Rodriguez de la Vega P, Zevallos JC, Barengo NC (2018) The association between race and survival in glioblastoma patients in the US: a retrospective cohort study. PLoS ONE 13:e0198581. https://doi.org/10.1371/journal.pone.0198581

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Warren KT, Liu L, Liu Y, Milano MT, Walter KA (2019) The impact of timing of concurrent chemoradiation in patients with high-grade glioma in the era of the stupp protocol. Front Oncol 9:186–186. https://doi.org/10.3389/fonc.2019.00186

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ahn S, Park JS, Song JH, Jeun SS, Hong YK (2020) Effect of a time delay for concomitant chemoradiation after surgery for newly diagnosed glioblastoma: a single-institution study with subgroup analysis according to the extent of tumor resection. World Neurosurg 133:e640–e645. https://doi.org/10.1016/j.wneu.2019.09.122

    Article  PubMed  Google Scholar 

  14. Buszek SM, Al Feghali KA, Elhalawani H, Chevli N, Allen PK, Chung C (2020) Optimal timing of radiotherapy following gross total or subtotal resection of glioblastoma: a real-world assessment using the national cancer database. Sci Rep 10:4926. https://doi.org/10.1038/s41598-020-61701-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Katsigiannis S, Krischek B, Barleanu S, Grau S, Galldiks N, Timmer M, Kabbasch C, Goldbrunner R, Stavrinou P (2019) Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma. Radiat Oncol 14:73. https://doi.org/10.1186/s13014-019-1272-6

    Article  PubMed  PubMed Central  Google Scholar 

  16. Pollom EL, Fujimoto DK, Han SS, Harris JP, Tharin SA, Soltys SG (2018) Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival. J Radiat Res 59:i11–i18. https://doi.org/10.1093/jrr/rrx103

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wright JM, Hodges TR, Wright CH, Gittleman H, Zhou X, Duncan K, Kruchko C, Sloan A, Barnholtz-Sloan JS (2019) Racial/ethnic differences in survival for patients with gliosarcoma: an analysis of the National cancer database. J Neurooncol 143:349–357. https://doi.org/10.1007/s11060-019-03170-7

    Article  CAS  PubMed  Google Scholar 

  18. National Cancer Database (2020) National Cancer Database Participant User File: 2017 Data Dictionary. https://www.facs.org/-/media/files/quality-programs/cancer/ncdb/puf_data_dictionary_2017.ashx. Accessed 15 Feb 2021

  19. R Core Team (2020) R: A language and environment for statistical computing. R foundation for statistical computing. http://www.R-project.org/. Accessed 21 July 2020

  20. Kassambara A, Kosinski M, Biecek P, Fabian S (2020) survminer: Drawing Survival Curves using 'ggplot2'. https://rpkgs.datanovia.com/survminer/index.html. Accessed 21 July 2020

  21. Heinzen E, Sinnwell J, Atkinson E, Gunderson T, Dougherty G, Votruba P, Lennon R, Hanson A, Goergen K, Lundt E, Broderick B, McCullough M (2020) arsenal: an arsenal of ‘R’ functions for large-scale statistical summaries. https://github.com/mayoverse/arsenal. Accessed 22 July 2020

  22. Wickham H, Averick M, Bryan J, Chang W, McGowan LDA, François R, Grolemund G, Hayes A, Henry L, Hester J, Kuhn M, Pedersen TL, Miller E, Bache SM, Müller K, Ooms J, Robinson D, Seidel DP, Spinu V, Takahashi K, Vaughan D, Wilke C, Woo K, Yutani H (2019) Welcome to the Tidyverse. J Open Source Softw 4:1686. https://doi.org/10.21105/joss.01686

    Article  Google Scholar 

  23. Dardis C (2018) survMisc: miscellaneous functions for survival data. https://github.com/dardisco/survMisc. Accessed 22 July 2020

  24. Soetaert K (2017) diagram: functions for visualising simple graphs (networks), plotting flow diagrams. https://CRAN.R-project.org/package=diagram. Accessed 24 July 2020

  25. Therneau TM (2020) A package for survival analysis in R. R package version 3.2-7. https://CRAN.R-project.org/package=survival. Accessed 15 Feb 2021

  26. Mogensen UB, Ishwaran H, Gerds TA (2012) Evaluating random forests for survival analysis using prediction error curves. J Stat Softw 50:23. https://doi.org/10.18637/jss.v050.i11

    Article  Google Scholar 

  27. Chandra A, Rick JW, Dalle Ore C, Lau D, Nguyen AT, Carrera D, Bonte A, Molinaro AM, Theodosopoulos PV, McDermott MW, Berger MS, Aghi MK (2018) Disparities in health care determine prognosis in newly diagnosed glioblastoma. Neurosurg Focus 44:E16. https://doi.org/10.3171/2018.3.Focus1852

    Article  PubMed  PubMed Central  Google Scholar 

  28. Cote DJ, Ostrom QT, Gittleman H, Duncan KR, CreveCoeur TS, Kruchko C, Smith TR, Stampfer MJ, Barnholtz-Sloan JS (2019) Glioma incidence and survival variations by county-level socioeconomic measures. Cancer 125:3390–3400. https://doi.org/10.1002/cncr.32328

    Article  PubMed  PubMed Central  Google Scholar 

  29. Brown DA, Himes BT, Kerezoudis P, Chilinda-Salter YM, Grewal SS, Spear JA, Bydon M, Burns TC, Parney IF (2018) Insurance correlates with improved access to care and outcome among glioblastoma patients. Neuro Oncol 20:1374–1382. https://doi.org/10.1093/neuonc/noy102

    Article  PubMed  PubMed Central  Google Scholar 

  30. Liu EK, Yu S, Sulman EP, Kurz SC (2020) Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma. J Neurooncol 149:55–64. https://doi.org/10.1007/s11060-020-03572-y

    Article  PubMed  Google Scholar 

  31. Wang T, Pham A, Yoo S, Attenello FJ, Jennelle R, Wagle N, Chang EL, Zada G (2020) Identifying disparities in care in treating glioblastoma: a retrospective cohort study of patients treated at a safety-net versus private hospital setting. World Neurosurg 137:e213–e220. https://doi.org/10.1016/j.wneu.2020.01.133

    Article  PubMed  Google Scholar 

  32. Cioffi G, Cote DJ, Ostrom QT, Kruchko C, Barnholtz-Sloan JS (2020) Association between urbanicity and surgical treatment among patients with primary glioblastoma in the United States. Neurooncol Pract 7:299–305. https://doi.org/10.1093/nop/npaa001

    Article  PubMed  Google Scholar 

  33. Lopez Ramos C, Brandel MG, Steinberg JA, Wali AR, Rennert RC, Santiago-Dieppa DR, Sarkar RR, Pannell JS, Murphy JD, Khalessi AA (2019) The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma. J Neurooncol 141:159–166. https://doi.org/10.1007/s11060-018-03022-w

    Article  PubMed  Google Scholar 

  34. Boffa DJ, Rosen JE, Mallin K, Loomis A, Gay G, Palis B, Thoburn K, Gress D, McKellar DP, Shulman LN, Facktor MA, Winchester DP (2017) Using the National Cancer database for outcomes research: a review. JAMA Oncol 3:1722–1728. https://doi.org/10.1001/jamaoncol.2016.6905

    Article  PubMed  Google Scholar 

  35. Lerro CC, Robbins AS, Phillips JL, Stewart AK (2013) Comparison of cases captured in the national cancer data base with those in population-based central cancer registries. Ann Surg Oncol 20:1759–1765. https://doi.org/10.1245/s10434-013-2901-1

    Article  PubMed  Google Scholar 

  36. Ostrom QT, Kinnersley B, Armstrong G, Rice T, Chen Y, Wiencke JK, McCoy LS, Hansen HM, Amos CI, Bernstein JL, Claus EB, Eckel-Passow JE, Il’yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Rubin JB, Andersson U, Rajaraman P, Chanock SJ, Linet MS, Wang Z, Yeager M, Houlston RS, Jenkins RB, Wrensch MR, Melin B, Bondy ML, Barnholtz-Sloan JS (2018) Age-specific genome-wide association study in glioblastoma identifies increased proportion of ’lower grade glioma’-like features associated with younger age. Int J Cancer 143:2359–2366. https://doi.org/10.1002/ijc.31759

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

QTO is supported by a Research Training Grant from the Cancer Prevention and Research Institute of Texas (CPRIT; RP160097T).

Author information

Authors and Affiliations

Authors

Contributions

QTO and JSB designed the project. QTO, GC and NP planned analytic approach. QTO performed all analyses. QTO and HK wrote the manuscript. All authors discussed the results and commented on the manuscript.

Corresponding author

Correspondence to Jill S. Barnholtz-Sloan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 147 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ostrom, Q.T., Krebs, H.L., Patil, N. et al. Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US. J Neurooncol 152, 603–615 (2021). https://doi.org/10.1007/s11060-021-03736-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-021-03736-4

Keywords

Navigation